Environment and Biotechnology Centre, Faculty of Life and Social Sciences, Swinburne University of Technology, PO Box 218, Hawthorn 3122 VIC, Australia.
BMC Complement Altern Med. 2012 Jun 19;12:77. doi: 10.1186/1472-6882-12-77.
Traditional Indian and Australian medicinal plant extracts were investigated to determine their therapeutic potential to inhibit key enzymes in carbohydrate metabolism, which has relevance to the management of hyperglycemia and type 2 diabetes. The antioxidant activities were also assessed.
The evaluation of enzyme inhibitory activity of seven Australian aboriginal medicinal plants and five Indian Ayurvedic plants was carried out against α-amylase and α-glucosidase. Antioxidant activity was determined by measuring (i) the scavenging effect of plant extracts against 2, 2-diphenyl-1-picryl hydrazyl (DPPH) and 2, 2'-azinobis-3-ethylbenzothiazoline-6-sulfonate (ABTS) and (ii) ferric reducing power. Total phenolic and total flavonoid contents were also determined.
Of the twelve plant extracts evaluated, the highest inhibitory activity against both α-amylase and α-glucosidase enzymes was exerted by Santalum spicatum and Pterocarpus marsupium with IC50 values of 5.43 μg/ml and 0.9 μg/ml, respectively, and 5.16 μg/ml and 1.06 μg/ml, respectively. However, the extracts of Acacia ligulata (IC50 = 1.01 μg/ml), Beyeria leshnaultii (0.39 μg/ml), Mucuna pruriens (0.8 μg/ml) and Boerhaavia diffusa (1.72 μg/ml) exhibited considerable activity against α-glucosidase enzyme only. The free radical scavenging activity was found to be prominent in extracts of Acacia kempeana, Acacia ligulata followed by Euphorbia drummondii against both DPPH and ABTS. The reducing power was more pronounced in Euphorbia drummondii and Pterocarpus marsupium extracts. The phenolic and flavonoid contents ranged from 0.42 to 30.27 μg/mg equivalent of gallic acid and 0.51 to 32.94 μg/mg equivalent of quercetin, respectively, in all plant extracts. Pearson's correlation coefficient between total flavonoids and total phenolics was 0.796.
The results obtained in this study showed that most of the plant extracts have good potential for the management of hyperglycemia, diabetes and the related condition of oxidative stress.
为了确定传统的印度和澳大利亚药用植物提取物抑制碳水化合物代谢关键酶的治疗潜力,从而有助于控制高血糖和 2 型糖尿病,我们对其进行了研究。同时还评估了它们的抗氧化活性。
我们对 7 种澳大利亚土著药用植物和 5 种印度阿育吠陀药用植物的酶抑制活性进行了评估,研究对象为α-淀粉酶和α-葡萄糖苷酶。通过测量(i)植物提取物对 2,2-二苯基-1-苦基肼(DPPH)和 2,2'-联氮-双-3-乙基苯并噻唑啉-6-磺酸(ABTS)的清除作用,以及(ii)铁还原能力,来测定抗氧化活性。还测定了总酚和总类黄酮的含量。
在所评估的 12 种植物提取物中,桑塔卢姆·斯皮卡特(Santalum spicatum)和紫檀(Pterocarpus marsupium)对α-淀粉酶和α-葡萄糖苷酶的抑制活性最高,IC50 值分别为 5.43μg/ml 和 0.9μg/ml,5.16μg/ml 和 1.06μg/ml。然而,金合欢属植物(Acacia ligulata)(IC50=1.01μg/ml)、贝雷利亚·莱什瑙蒂(Beyeria leshnaultii)(0.39μg/ml)、穆库纳普鲁里恩斯(Mucuna pruriens)(0.8μg/ml)和博尔哈维亚·迪菲杜萨(Boerhaavia diffusa)(1.72μg/ml)的提取物对α-葡萄糖苷酶也表现出相当的活性。结果表明,在 DPPH 和 ABTS 中,金合欢属植物(Acacia kempeana)和金合欢属植物(Acacia ligulata)的提取物表现出显著的自由基清除活性,其次是大戟属植物(Euphorbia drummondii)。Euphorbia drummondii 和紫檀(Pterocarpus marsupium)提取物的还原能力更为明显。在所有植物提取物中,酚类和类黄酮的含量范围分别为 0.42 至 30.27μg/mg 没食子酸当量和 0.51 至 32.94μg/mg 槲皮素当量。所有植物提取物中总类黄酮和总酚类之间的皮尔逊相关系数为 0.796。
本研究结果表明,大多数植物提取物具有很好的控制高血糖、糖尿病及其相关氧化应激状态的潜力。